Open Access

Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis

  • Azadeh Mizani1, 2, 3,
  • Abbas Alipour4,
  • Mehdi Sharif1, 2,
  • Shahabeddin Sarvi1, 2,
  • Afsaneh Amouei1, 2,
  • Azar Shokri1, 2,
  • Mohammad-Taghi Rahimi1, 2,
  • Seyed Abdollah Hosseini1, 2 and
  • Ahmad Daryani1, 2Email author
Tropical Medicine and Health201745:7

DOI: 10.1186/s41182-017-0048-7

Received: 14 December 2016

Accepted: 31 March 2017

Published: 12 April 2017

Abstract

Background

Toxoplasmosis is caused by an intracellular obligatory parasite, Toxoplasma gondii, and it has global distribution. The purposes of this systematic review and meta-analysis were to evaluate the seroprevalence of toxoplasmosis in Iranian pregnant women, and girls and women of childbearing age, and identify potentially preventable risk factors.

Methods

Between November 2014 and February 2017, nine electronic databases that reported data on the T. gondii seroprevalence in Iranian women were searched. Our search resulted in 83 reports published from 1994 to 2017.

Results

The results showed that the pooled estimation for the prevalence of T. gondii using a random-effect model was 43% (95% confidence interval (CI) = 38–48%) in pregnant women and 33% (95% CI = 23–43%) in girls and the childbearing age groups. There was a significant association between the T. gondii seroprevalence with age and the gestational age of conception in pregnant women and those who had contact with cats in both groups.

Conclusions

This is the first comprehensive systematic review of T. gondii infection seroprevalence in Iranian women, which showed a high prevalence of Toxoplasma infection. Around 57% of pregnant women and 67% of girls and the childbearing age groups were seronegative and thus were susceptible to infection and should be monitored.

Keywords

Toxoplasmosis Toxoplasma gondii Pregnant women Women Girls Seroprevalence Systematic review Iran

Background

Toxoplasmosis, a cosmopolitan infection in humans and animals, is caused by an intracellular obligatory parasite, Toxoplasma gondii [1]. T. gondii is spread worldwide, as at least one third of the world’s population is infected [2]. The broad geographic location of toxoplasmosis is associated with several risk factors such as the geographical climate, contact with cats or other pet’s faeces, nutritional habits, and location of one’s residence [3]. The worldwide prevalence of antibodies against T. gondii varies from 30 to 60% in both developing and developed countries [4]. Infection is acquired by accidentally ingesting oocysts in food, water, and soil contaminated with cat faeces or the consumption of raw meat containing tissue cysts [5, 6].

Toxoplasmosis can lead to life-threatening conditions in high-risk groups such as pregnant women, immunodeficient individuals (e.g. HIV-positive patients, organ transplant recipients, and patients with cancer) [7, 8]. Although T. gondii remains dormant in healthy individuals, exposure to parasites during pregnancy can lead to vertical transmission to the embryo [9]. The incidence of maternal infection during pregnancy is 1–8 per 1000 pregnancies [10]. A newborn exposed to T. gondii may develop congenital toxoplasmosis with microcephaly, hydrocephaly, blindness, spontaneous abortion, and stillbirth [9]. It may also significantly reduce the quality of life in children who survive prenatal infection and affect the socioeconomic burden on the patient’s family and the government [11]. It is important to determine whether infection occurs in the early stage of conception or before because women who have been exposed to infection prior to pregnancy are not at risk of having an infected child [12]. Exceptions have been seen in immunodeficient mothers [13]. Screening for anti-Toxoplasma antibodies in pregnant women and also non-immune girls of childbearing age is the mainstay for controlling and preventing congenital infection [9, 11, 14].

Because of its importance and the fact that T. gondii is ubiquitous, seroepidemiologic studies help establish the health policies of each country. The purposes of this systematic review and meta-analysis were as follows: (1) to evaluate the seroprevalence of toxoplasmosis in Iranian pregnant women, (2) to estimate the prevalence of T. gondii in girls and women of childbearing age, (3) to identify the potentially preventable risk factors most likely to have the greatest impact on the incidence of Toxoplasma infection in pregnancy, and (4) to determine whether seronegative women are a high-risk group for toxoplasmosis that need specific control and prevention strategies to reduce the level of Toxoplasma infection.

Methods

The following four literature search strategies were used in this systematic review and meta-analysis: (1) computer search, (2) study selection, (3) data synthesis, and (4) data analysis and quality assessment.

Computer search

Six English language databases (i.e. PubMed, ScienceDirect, Scopus, Google Scholar, ClinicalTrials.gov, and Cochrane Library) and three Persian databases (i.e. Scientific Information Database, Magiran, and Iran Medex) were searched from 1994 to 2017. The search was restricted to English- and Persian language databases. Medical Subject Heading terms and keywords included Toxoplasma gondii, toxoplasmosis, women, girl, pregnant women, childbearing age women, abortion, seroprevalence, seroepidemiology, Iran, and Islamic Republic of Iran. All citations were downloaded into EndNote.

Study selection

Abstracts were reviewed independently by 4 authors, and cross-sectional studies that estimated the seroprevalence of Toxoplasma infection in pregnant women, women of childbearing age, women with an abortion, student girls from a university or high school, and girls referred to health centres for premarital laboratory tests or a medical laboratory for routine tests, except T. gondii, were selected for further use.

The final decisions about the inclusion or exclusion of studies were made separately after inspection. Discrepancies were resolved by discussion and consensus. In addition, the collected bibliographic publications were screened carefully, and duplicate articles, studies based in Iran, animal-based studies, and those with a specific population (e.g. the general population and all immunocompromised groups) were also excluded.

Data synthesis

A protocol for data extraction was defined with groups. Data were extracted from selected publications using a data extraction sheet by authors, and then, the data were reviewed by a third author. The following data were extracted from the literature: first author, geographical region, the year of publication, diagnostic method with the cut-off value, total individuals, number of immunoglobulin (Ig)G-positive and IgG-negative cases, number of IgM-positive and IgM-negative cases, and number of both IgG- and IgM-positive cases among the study groups.

All information included demographic factors such as contact with cats and other animals, the consumption of raw fruits and vegetables, washing methods, the consumption of undercooked meat and unpasteurized milk, age, occupational group, education level, place of residence, number of pregnancies and abortions, and gestation age of the total individuals and positive cases. Whether the subjects wore gloves when cutting meat and had contact with soil was also collected. Figure 1 shows a diagram describing the study design process.
Fig. 1

Flow diagram of the study design process

Data analysis and quality assessment

The formula to calculate the population prevalence (weighed prevalence (WP)) of T. gondii in all groups or subgroups, included in this meta-analysis, was P = ∑ (pi) (1/vi)/∑ 1/vi. We used the metaprop command of STATA, version 12.1 (StataCorp, College Station, TX, USA), for pooling proportions. We estimated 95% confidence intervals (CIs) using the score statistic and the exact binomial method, and Freeman-Tukey double arcsine transformation of proportions via the ftt option. Forest plots were drawn to display the variation of the seroprevalence of the Toxoplasma infection test positivity rate among all studies together with the pooled measure and subgroup analysis. Heterogeneity of the prevalence estimates between studies was determined by the Q statistic and I 2 index, assuming that I 2 values of 25, 50, and 75% represented low, medium, and high heterogeneity, respectively. Therefore, we assess the quality of each study (Additional file 1: Table S1 and Additional file 2: Table S2). The influence of study characteristics (e.g. contact with cats and other pets; the consumption of raw meat, milk, soil, fruits, and vegetables; washing methods; age; occupational group; education level; place of residence; number of pregnancies and abortions; gestation age; the use of gloves when cutting meat; and study quality) was explored using subgroup analysis and meta-regression.

Results

Of 97,553 literature searches from nine databases, 83 records were eligible to include in this systematic review and meta-analysis. Thirty-eight articles reported results about the seroprevalence of toxoplasmosis in women and girls of childbearing age, 45 about the seroprevalence of Toxoplasma infection among pregnant women. Approximately all the studies included in this meta-analysis had a cross-sectional design. Of 40,117 individuals, 16,698 cases had Ig against T. gondii and were included in the meta-analysis, followed by 39,837 individuals, with 15,822 positive cases for IgG, 16,590 with 652 positive cases for IgM, and 5447 with 224 cases positive for both IgG and IgM.

The prevalence of anti-Toxoplasma seropositivity in the girls group (i.e. women of childbearing age, high school girls, girl students from a university, girls referred to a health centre for pre-marriage examination, and non-pregnant women sent to a medical laboratory for examination) based on the random-effect model was 33% (95% CI = 23–43%). Figure 2 shows the forest plot diagram. About 67% of girls were seronegative and were not immune. The pooled estimations of IgG, IgM, and both IgG- and IgM-positive cases were 31% (95% CI = 21–41%), 5% (95% CI = 3–6%), and 3% (95% CI = 2–5%), respectively. Table 1 shows the baseline characteristic of the included studies.
Fig. 2

Random-effect meta-analysis of pooled estimation of Toxoplasma gondii in girls and women of childbearing age group

Table 1

Girls and women of childbearing age group baseline characteristics of included studies

Province

Total individuals

IgG-positive cases (%)

IgM-positive cases (%)

IgG- and IgM-positive cases (%)

Total prevalence (%)

Authors

Kerman

350

103 (29.42)

18 (5.14)

13 (3.71)

134 (38.28)

Kamyabi et al., 1999

Mazandaran

980

731 (74.59)

  

731 (74.59)

Ajami et al., 2001

Isfahan

273

132 (48.35)

  

132 (48.35)

Mostafavi Zadeh et al., 2002

West Azerbaijan

300

98 (32.66)

12 (4)

 

110 (36.66)

Taravati et al., 2002

Hamedan

360

140 (38.88)

  

140 (38.88)

Rabiee et al., 2003

Isfahan

414

76 (18.35)

  

76 (18.35)

Mahmoudi et al., 2005

Fars

947

96 (10.13)

  

96 (10.13)

Hatamet al., 2005

East Azerbaijan

1000

218 (21.8)

  

218 (21.8)

Fallah et al., 2005

Khuzestan

259

12 (4.63)

  

12 (4.63)

Rafiei et al., 2005

Ardabil

504

175 (34.72)

20 (3.96)

 

195 (38.69)

Daryani et al., 2006

Golestan

300

145 (48.33)

35 (11.66)

29 (9.66)

209 (69.66)

Saeedi et al., 2007

Mazandaran

241

154 (63.9)

30 (12.44)

 

184 (76.34)

Yousefi et al., 2007

Tehran

707

119 (16.83)

17 (2.4)

 

136 (19.23)

Chamani et al., 2007

Kurdistan

600

169 (28.16)

  

169 (28.16)

Mohammadi et al., 2008

Kerman

549

93 (16.93)

  

93 (16.93)

Haj ghani et al., 2008

Ardabil

272

115 (42.27)

 

3(1.1)

118 (43.38)

Ali Mohammadi et al., 2008

Khuzestan

400

103 (25.75)

  

103 (25.75)

Ziaei kajbaf et al., 2008

Lorestan

465

452 (97.2)

  

452 (97.2)

Fallahi et al., 2009

Isfahan

400

79 (19.75)

3 (0.75)

 

82 (20.5)

Arbabi et al., 2009

Qazvin

400

136 (34)

  

136 (34)

Jahani Hashemi et al., 2010

Bushehr

491

54 (10.99)

8 (1.62)

5(1.01)

67 (13.64)

Fouladvand et al., 2010

Bushehr

516

114 (22.09)

7 (1.35)

 

121 (23.44)

Fouladvand et al., 2010

Bushehr

303

71 (23.43)

10 (3.3)

 

81 (26.73)

Fouladvand et al., 2010

Sistan and Baluchestan

280

 

15 (5.35)

 

15 (5.35)

Khazaie et al., 2011

South Khorasan

300

37 (12.33)

  

37 (12.33)

Namayee et al., 2011

Razavi Khorasan

240

35 (14.58)

  

35 (14.58)

Heydari et al., 2011

Isfahan

217

103 (47.46)

  

103 (47.46)

Mostafavi et al., 2012

Sistan and Baluchestan

280

79 (28.21)

  

79 (28.21)

Khazaei et al., 2012

Khuzestan

240

28 (11.66)

29 (12.08)

7 (2.91)

64 (26.66)

Maraghi et al., 2013

East Azerbaijan

1659

898 (54.12)

  

898 (54.12)

Rajaii et al., 2013

North Khorasan

215

44 (20.46)

  

44 (20.46)

Ali Asghari, et al., 2013

Tehran

300

85 (28.33)

4 (1.33)

3 (1)

92 (30.66)

Ghadamgahi et al., 2013

Mazandaran

800

453 (56.62)

  

453 (56.62)

Barari Sawadkohi et al., 2013

Fars

403

52 (12.9)

8 (1.98)

 

60 (14.88)

Davami et al., 2013

Chaharmahal and Bakhtiari

338

126 (37.27)

  

126 (37.27)

Manouchehri et al., 2014

Ilam

260

55 (21.15)

  

55 (21.15)

Kamran et al., 2014

East Azerbaijan

549

88 (16.02)

66 (12.02)

34 (6.19)

188 (34.24)

Fallah et al., 2014

Markazi

400

97 (24.25)

19 (4.75)

 

116 (29)

Mohammadi et al., 2015

Data analysis showed that there was a significant relationship between Toxoplasma seropositivity and contact with cats (P = 0.04). Although the seroprevalence of Toxoplasma infection was higher among individuals who had direct contact with cats (30%); groups without contact with other animals (26%); individuals who consumed raw meat (34%), milk (45%), and fruits or vegetables (24%); individuals who washed vegetables or fruits with water (27%) and cut meat without wearing gloves (18%); individuals who had a low education level (63%); and those who were employed (53%) and were aged >20 years, there were no associations between these aforementioned factors and the rate of Toxoplasma infection. Table 2 shows the overall characteristics of the risk factors of the included studies.
Table 2

Risk factors associated to seropositivity for Toxoplasma gondii in girls and women of childbearing age group

Demographic factors

Total individuals

Positive cases

Pooled estimation (%)

I 2

P valuea

Age

0.62

 ≤20 years

2296

1040

45 (95% CI = 30 to 60)

98.91

 >20 years

4370

2294

39 (95% CI = 23 to 56)

98.49

Contact with cat

0.04

 Yes

1775

474

30 (95% CI = 24 to 37)

87.44

 No

3898

815

21 (95% CI = 16 to 26)

93.78

Contact with other animals

0.41

 Yes

657

182

26 (95% CI = 18 to 35)

82.33

 No

1443

295

21 (95% CI = 12 to 30)

94.98

Contact to meat

0.98

 Yes

646

204

28 (95% CI = 16 to 42)

89.59

 No

339

82

23 (95% CI = 19 to 28)

96.53

Meat consumption

0.12

 Undercooked

1755

466

34 (95% CI = 23 to 46)

95.33

 Cooked

2209

381

17 (95% CI = 12 to 22)

89.25

Raw vegetable/fruit consumption

0.25

 Yes

2645

631

24 (95% CI = 17 to 31)

94.49

 No

 

47

17 (95% CI = 9 to 27)

71.32

Milk consumption

0.17

 Pasteurized

1264

276

21 (95% CI = 8 to 38)

97.87

 Unpasteurized

95

34

45 (95% CI = 19 to 72)

78.93

Educational status

0.37

 Illiterate

211

114

63 (95% CI = 37 to 86)

91.70

 

 Junior/senior

1064

553

50 (95% CI = 30 to 70)

97.73

 

 High school

987

555

52 (95% CI = 24 to 80)

98.89

 

 Diploma/university

863

320

47 (95% CI = 18 to 77)

98.80

 

Occupational group

0.37

 Employee

572

340

53 (95% CI = 33 to 74)

99.17

 

 Housewife

2389

1336

52 (95% CI = 30 to 73)

95.28

 

 Students

418

133

83 (95% CI = 16 to 63)

95.95

 

Wearing gloves during cutting meat

0.47

 Yes

250

31

12 (95% CI = 8 to 17)

96.78

 

 No

756

137

18 (95% CI = 15 to 20)

96.78

 

Washing vegetable/fruit

0.65

 Water

573

176

27 (95% CI = 12 to 46)

95.36

 

 Antiseptic

705

107

19 (95% CI = 10 to 31)

89.76

 

Residence

0.99

 Urban

5137

2011

33 (95% CI = 19 to 49)

99.27

 

 Rural

2924

1213

33 (95% CI = 22 to 46)

97.53

 

aMeta-regression analysis

The pooled estimation for the prevalence of anti-Toxoplasma antibodies in pregnant women using the random-effect model was 43% (95% CI = 38–48%). Figure 3 shows the forest plot diagram. The data indicated that 57% of pregnant women were seronegative and were not immune during pregnancy. Table 3 demonstrates the baseline characteristics of the included data. The pooled estimates of IgG, IgM, and both IgG- and IgM-positive cases were 40% (95% CI = 35–45%), 3% (95% CI = 2–4%), and 4% (95% CI = 2–5%), respectively.
Fig. 3

Forest plot diagram of total prevalence of Toxoplasma gondii in pregnant women group

Table 3

Pregnant women group baseline characteristics of included studies

Province

Total individuals

IgG-positive cases (%)

IgM-positive cases (%)

IgG- and IgM-positive cases (%)

Total prevalence (%)

Authors

Kermanshah

495

162(32.72)

  

162(32.72)

Athari et al., 1994

Mazandaran

612

435(71.07)

  

435(71.07)

Saffar et al., 1999

Isfahan

317

98(30.91)

4(1.26)

 

102(32.17)

Talari et al., 2001

Isfahan

340

207(60.88)

  

207(60.88)

Arbabi et al., 2002

Tehran

4120

2804(68.05)

  

2804(68.05)

Gharavi et al., 2002

Tehran

140

48(34.28)

10(7.14)

 

58(41.42)

Noorbakhsh et al., 2002

Isfahan

270

72(26.66)

15(5.55)

 

87(32.22)

Talari et al., 2003

Hormozgan

418

143(34.21)

33(7.89)

10(2.39)

186(44.49)

SotoudehJahromi et al., 2003

Qom

600

257(42.83)

  

257(42.83)

Mardani et al., 2003

Sistan and Baluchestan

200

54(27)

  

54(27)

Sharifi Mood et al., 2004

Chaharmahal and Bakhtiari

384

106(27.60)

  

106(27.60)

Manuchehri et al., 2007

Khuzestan

79

28(35.44)

  

28(35.44)

Sohrabi et al., 2007

Ilam

553

247(44.66)

  

247(44.66)

Abdi et al., 2008

Hamedan

576

193(33.50)

  

193(33.50)

Fallah et al., 2008

Qazvin

255

160(62.74)

  

160(62.74)

Eskandarian et al., 2009

Kurdistan

201

54(26.86)

24(11.94)

33(16.41)

111(55.22)

Parvizpour et al., 2010

Lorestan

390

121(31.02)

29(7.43)

 

150(38.46)

Cheraghi Pour et al., 2010

Lorestan

331

130(39.27)

35(10.57)

 

165(49.84)

Cheraghi Pour et al., 2010

Isfahan

127

67(52.75)

  

67(52.75)

Ghasemi et al., 2011

Zanjan

500

186(37.2)

7(1.4)

 

193(38.60)

Hajsoleimani et al., 2012

Hormozgan

608

252(41.44)

  

252(41.44)

JamshidiMakiani et al., 2012

East Azerbaijan

300

79(26.33)

1(0.33)

 

80(26.66)

DalimiAsl et al., 2012

Mazandaran

1057

739(69.91)

57(5.39)

 

796(75.30)

SiyadatPanah et al., 2013

Qom

200

76(38)

11(5.5)

 

87(43.50)

Akhlaghi et al., 2013

Razavi Khorasan

419

144(34.36)

 

27(18.75)a

171(40.81)

Babaie et al., 2013

Hamedan

350

105(30)

 

3(2.85)b

108(30.85)

Maghsood et al., 2013

Sistan and Baluchestan

221

68(30.76)

3(1.35)

3(1.35)

74(33.48)

Ebrahimzadeh et al., 2013

Lorestan

496

154(31.04)

 

35(22.72)c

189(38.10)

RostamiNejad et al., 2013

Qom

400

145(36.25)

21(5.25)

 

166(41.50)

Maleki et al., 2013

Markazi

308

117(37.98)

 

3(1.74)d

120(38.96)

Vakil et al., 2014

Mazandaran

289

170(58.82)

7(2.42)

4(1.38)

181(62.62)

Hoseini et al., 2014

Sistan and Baluchestan

185

19(10.27)

1(0.54)

1(0.54)

21(11.35)

Mousavi et al., 2014

Mazandaran

175

106(60.57)

  

106(60.57)

Kalantari et al., 2014

Golestan

555

221(39.81)

19(3.42)

8(1.44)

248(44.68)

Sharbatkhori et al., 2014

Khuzestan

501

137(27.34)

7(1.39)

3(0.59)

147(29.34)

Yadyad et al., 2014

Tehran

785

244(31.08)

  

244(31.08)

Ghasemloo et al., 2014

East Azerbaijan

195

115(58.97)

  

115(58.97)

Haji SeidJavadi et al., 2014

Mazandaran

50

26(52)

  

26(52)

ElahianFirouz et al., 2014

Yazd

181

58(32.04)

  

58(32.04)

Anvari et al., 2014

Alborz

400

116(29)

4(1)

 

120(30)

Akhlaghi et al., 2014

Isfahan

798

341(42.73)

5(0.62)

 

346(43.35)

Rasti et al., 2015

Qazvin

200

58(29)

4(2)

 

62(31)

Tabatabaieet al., 2015

East Azerbaijan

391

267(68.28)

  

267(68.28)

Rajaii et al., 2015

Hamedan

2523

681(26.99)

51(2.02)

 

732(29.01)

Hamidi et al., 2015

Khuzestan

110

47(42.72)

3(2.72)

 

50(45.45)

Saki et al., 2016

aTotal individuals for IgM seropositivity is 144

bTotal individuals for IgM seropositivity is 105

cTotal individuals for IgM seropositivity is 154

dTotal individuals for IgM seropositivity is 172

In this group, there was a significant association among age groups (P = 0.004), contact with cats (P = 0.005), gestation age of the pregnant women (P = 0.001), and the rate of infection. Data indicated that although the prevalence of T. gondii infection was higher among individuals who had direct contact with soil (42%); consumed raw meat (41%) and fruits or vegetables (39%); washed vegetables or fruits with water (39%); lived in rural areas (47%); had a senior-junior high school education level (39%); and were aged >30 years (53%), there were no associations between these aforementioned factors and T. gondii antibody positivity. Table 4 shows the overall characteristics of the described risk factors.
Table 4

Risk factors associated to seropositivity for Toxoplasma gondii in pregnant women group

Demographic factors

Total individuals

Positive cases

Pooled estimation (%)

I 2

P valuea

Age

0.004

 ≤30 years

5332

2041

34 (95% CI = 26 to 43)

97.69

 >30 years

1414

772

53 (95% CI = 45 to 61)

87.70

Contact with cat

0.005

 Yes

1779

787

44 (95% CI = 36 to 52)

89.17

 No

2410

716

27 (95% CI = 20 to 34)

92.53

Contact with soil

0.92

 Yes

63

27

42 (95% CI = 30 to 54)

92.72

 No

929

310

33 (95% CI = 30 to 36)

92.72

Meat consumption

0.4

 Undercooked

1450

603

41 (95% CI = 28 to 53)

95.05

 Cooked

1814

645

35 (95% CI = 29 to 42)

88.62

Raw vegetable/fruit consumption

0.46

 Yes

1463

570

39 (95% CI = 25 to 54)

96.90

 No

520

164

31 (95% CI = 26 to 36)

29.12

Washing vegetable/fruit

0.64

 Water

847

358

39 (95% CI = 21 to 58)

96.85

 Antiseptic

602

212

34 (95% CI = 23 to 47)

88.09

Residence

0.55

 Rural

1796

762

47 (95% CI = 38 to 55)

91.72

 Urban

2361

1017

43 (95% CI = 34 to 52)

94.57

Occupational group

0.94

 Employee

143

68

47 (95% CI = 35 to 59)

48.56

 Housewife

1359

594

47 (95% CI = 39 to 55)

86.58

Educational status

0.67

 Illiterate

329

108

34 (95% CI = 25 to 44)

63.80

 

 Junior/senior

1617

665

39 (95% CI = 32 to 47)

88.35

 

 High school/diploma

1410

457

31 (95% CI = 26 to 36)

73.55

 

 University

493

189

36 (95% CI = 27 to 45)

76.63

 

Gestation age

0.001

 1st trimester

570

258

46 (95% CI = 40 to 51)

46.05

 

 2nd trimester

491

192

39 (95% CI = 35 to 43)

0

 

 3rd trimester

594

193

32 (95% CI = 29 to 36)

0

 

Number of pregnancy

0.42

 Null gravid

363

143

41 (95% CI = 23 to 61)

92.76

 

 Multi-gravid

452

228

53 (95% CI = 36 to 69)

92.16

 

History of abortion

0.22

 Yes

4285

1666

44 (95% CI = 37 to 50)

94.60

 

 No

3058

1170

38 (95% CI = 32 to 44)

90.93

 

aMeta-regression analysis

Discussion

T. gondii has a wide range of distribution, and seroprevalence data indicate that toxoplasmosis is one of the most common human infections worldwide [15]. Acute infection with Toxoplasma during pregnancy and its outcome for the foetus and newborn continue to occur in Iran and in other countries, despite the fact that it can be prevented. A large body of the research about the seroepidemiology of toxoplasmosis in women has been performed in Iran because of the great importance of T. gondii as a public health problem, but there is a lack of comprehensive systematic and documented data in this area.

Among all nine databases searched from November 2014 to February 2017, 83 records involving 40,117 individuals and 16,698 cases containing immunoglobulin against T. gondii in groups of women were eligible to be included in this systematic review and meta-analysis. The present study showed that the seroprevalence of anti-T. gondii antibodies in Iranian pregnant women and women of childbearing age were 43 and 33%, respectively. A higher prevalence of anti-T. gondii antibodies was observed in previous studies conducted in Iran: 55% in patients who had received transplants, 50% in HIV-infected individuals, and 45% in patients with cancer [16]. The prevalence of toxoplasmosis from a survey administered to the general population in Iran was 39.3% [9]. The data indicated that the seroprevalence of T. gondii in pregnant women in Europe varies from 9 to 67% [17]. Although some Asian countries such as Malaysia, India, and Nepal have the highest seroprevalence of Toxoplasma infection in pregnant women (41.8–55.4%), conversely, Korea and Vietnam report a low seropositivity rate of T. gondii (0.8 and 11.2%, respectively) [1820]. In our neighbouring countries, Turkey and Pakistan, the anti-Toxoplasma antibody in pregnant women was found to be 33 and 19.25%, respectively [21, 22]. However, in Turkey, the seroprevalence of Toxoplasma infection in women of reproductive age was determined to be 58.3 and 1% for IgG and IgM, respectively [23].

Toxoplasma infection’s geographical distribution is related to several environmental factors (i.e. food habits, variations in climate, and contact with infected cat faeces) and sociodemographic factors (i.e. age, occupation, education, and residence) [24]. Any of these factors alone has little effect on the epidemiological status of Toxoplasma infection, but together, they can change the distribution pattern of the disease worldwide [9].

The geographical climate is one of the main factors of the disease. Our country has an arid climate, but the weather condition is variable. Some provinces such as Tehran, Fars, Kerman, and Khuzestan have various climates. Thus, an epidemiologic survey in this part of Iran is more difficult to administer. This variation of climatic conditions can introduce biases into the prevalence rate of Toxoplasma infection. In the northern part of Iran (around the Caspian Sea), there is a high prevalence of T. gondii infection, whereas in cold mountainous and hot provinces, lower seropositivity rates are found. The right climate status in the northern part provides a suitable condition for oocyst sporulation and survival in the environment. In mild and wet climates, the maturation of oocysts and transmission to a new host happens [9, 25]. Additional file 3: Figure S1 shows the prevalence of total Toxoplasma antibodies in both girls and pregnant women in all parts of Iran.

The abundance of cats is another risk factor of Toxoplasma infection. Domestic cats are one of the main sources of infection. Our results showed that the anti-Toxoplasma antibody in cat and other pet owners was higher than that in individuals who did not own or have contact with domestic animals in both pregnant girls and those of childbearing age. Similar findings were reported by other studies [26, 27]. Cats excrete millions of oocysts after ingestion of even one tissue cyst or bradyzoite. In the environment, sporulated oocysts can outlast for months or even years in moist soil. Terrestrial insects such as earthworms, beetles, and even flies can extend oocysts from the soil, which leads to food contamination. Cats may be infected when hunting small mammals contaminated by tissue cysts. They can shed a large amount of oocysts via faeces in the environment. Food, water, farms, and gardens may be contaminated by their oocysts. Keeping cats in the house (e.g. keeping them indoors or outdoors), especially in high-risk groups such as seronegative pregnant women who are susceptible to Toxoplasma infection, needs more consideration [28]. Previous data have indicated that dog fur that has come in contact with cat faeces may be one of the factors of oocyst transmission to humans [2].

In our study, T. gondii showed a higher antibody titre in individuals who consume undercooked meat, milk, vegetables, and fruits and washed them with water only instead of detergent in both aforementioned groups. Lopes et al. and Gelaye et al. showed the same results [26, 29]. The consumption of meat from domestic animals contaminated with tissue cysts is one of the main sources of infection. The risk of acquiring T. gondii via contaminated meat with tissue cysts varies between cultural and eating habits in various communities. However, meat is one of the major sources of Iranian meals; thus, the consumption of undercooked meat can lead to the transmission of parasites. There is a risk of Toxoplasma infection by consuming dairy products. Tachyzoites are orally infectious because they can survive in pepsin and trypsin. The consumption of milk containing tachyzoites in girls and women of childbearing age with no prior contact to the organism can lead to horizontal transmission and clinical infection. In seronegative women during pregnancy, the consumption of undercooked meats such as kebab (a meat product like sausage), dairy products, raw vegetables, and fruits can lead to congenital toxoplasmosis, which is a serious problem [9, 30].

Our data showed that the seropositivity of T. gondii infection among various occupations in both groups was different. In women of childbearing age and the girls group, the seroepidemiology of T. gondii in employees was a little higher than other jobs, but this difference was not significant. Our result was comparable to a study performed in Brazil, which showed a high prevalence of infection in this group [27]. However, in pregnant women, antibody titres were the same in both groups. Women spend more time cooking, tasting foods during meal preparation, handling and chopping meat in the kitchen, taking care of pets at home, gardening, and cleaning and washing vegetables and fruits. This finding explains why the seropositivity of infection in individuals who have contact with soil during gardening and women who chop meat without wearing gloves is higher than that in groups who do not have exposure to soil and raw meat. In various parts of the world, T. gondii oocysts have been isolated from soil samples [2].

Published studies have indicated that in women of childbearing age, by increasing the level of education, a rising trend in T. gondii seropositivity was observed. Evidence from a study by Hung et al. supported our finding [31]. The authors suggested that women with an academic education should have more knowledge related to Toxoplasma biology and its prevention and control strategies. The lack of effective information about this disease such as the route of transmission during pregnancy and poor socioeconomic status can increase the risk of infection.

The seroprevalence and serologically positive cases increased by age in pregnant groups. Nimiri et al. demonstrated that a higher seropositivity rate was seen in older age groups than in younger age groups [32]. The reason for this has not yet been discussed and it is not clear, but authors suggested the following reasons for infection: the prolonged exposure to the risk factors, transmission route, and lack of public awareness about preventive methods.

In the current study, the seroprevalence of T. gondii in pregnant women who lived in rural areas was higher than those in urban areas. In 2009, Lopes et al. found similar results with our findings [26]. During the first trimester of pregnancy, the risk of acquired congenital infection and impact on the foetus is 10–15%. However, in the second and third trimesters, the risk of foetal infection increases (60–90%) and also the effects on the foetus are milder [30, 33].

In the present study, the seropositivity rate of infection in the first trimester of pregnancy was higher than that in the second and third trimesters. In all women during conception, ideally in the first trimester, a serological screening test for T. gondii IgG and IgM detection are feasible [34]. This kind of screening helps clinicians detect seroconversion individuals and provide early treatment for infection [35]. In our study, multi-gravid women had a higher prevalence of T. gondii infection, and the prevalence was proportionally increased with an increasing number of children. Null gravid women had a prevalence of 41%, whereas women with more than one child had a prevalence of 53%. Our results showed a trend towards an increasing risk of positive T. gondii antibodies with increasing parity. In our study, the rate of anti-Toxoplasma antibodies among women with spontaneous abortion was 44%. This finding is in agreement with reports from Taiwan and Ethiopia [29, 31].

The most commonly used serological method of available data on T. gondii epidemiologic survey in both groups was ELISA. ELISA is a quantitative and inexpensive tool with a sensitivity and specificity of 100 and 98.4%, respectively [24]. The second common serological method is IFA (sensitivity, 95%; specificity, 96%). Albeit IFA is cheap, manageable, and safe, it is a manual tool and ultraviolet light microscopy is needed [9]. Additional file 4: Table S3 and Additional file 5: Table S4 summarize the characteristic of methods used in the included studies.

The prevention and control of Toxoplasma infection rely on sufficient information about parasite epidemiology. The knowledge on T. gondii seroprevalence, risk factors, and prevention strategies can lead to efficient incidence reduction [36]. The general population knows little about congenital toxoplasmosis and the risk of disease. Awareness of the risk factors of toxoplasmosis makes it possible for health authorities to define specific preventive strategies for high-risk populations. Primary prevention includes educational materials that contain the routes of how to prevent infection in women during pregnancy, which have resulted in reducing the prevalence of the seroconversion population.

Secondary prevention includes serological screening. The transmission of T. gondii to the foetus always happens during or before conception. In healthy women with previous infection, transmission to the foetus rarely occurs [37]. In both IgG- and IgM-negative cases, there is no serologic evidence of prior exposure to T. gondii, and the risk of congenital toxoplasmosis is high. Thus, they require serial testing during gestation. Anti-Toxoplasma IgG-positive women should be tested for the IgM antibody, and in IgM-positive cases, confirmative tests are needed. In women with IgG-positive and IgM-negative antibodies, the gestation age is very important. In women at <18 weeks of gestation, it means past infection and the risk of congenital toxoplasmosis is zero. However, in women at >18 weeks of gestation, it is difficult to predict whether exposure happened in the past or during conception. In anti-Toxoplasma IgG-negative and IgM-positive cases, a serological test should be repeated after 3 weeks. In this group, two conditions can occur: the antibody titre persists (IgG− and IgM+) or the IgG antibody changes to positive (IgG+ and IgM+). Management of the first group is the same as that for IgG− and IgM− patients, and in the second group, seroconversion occurs. In this group, the risk of T. gondii transmission to the foetus is high, and treatment, amniotic fluid polymerase chain reaction, and ultrasound should be performed [34].

The results show that there is heterogeneity across the studies as illustrated by the forest plot. The dissimilarity, sensitivity, and specificity of several methods used in various studies, differences in the sample size, nutritional habits, and environmental factors such as the geographical climate can result in this heterogeneity.

There are many studies based on the seroepidemiologic survey on women with toxoplasmosis in Iran, but there has not been a comprehensive systematic and documented report on this topic, except two articles on the epidemiology of Toxoplasma in women, which were not comprehensive [10, 38]. The present article fulfils this gap. Our systematic review and meta-analysis has certain limitations. The major limitations include the following: (1) there was no uniform sample size, (2) different methods with various sensitivity and specificity were used, (3) and the epidemiological results were heterogeneous. These aforementioned factors may have biased the prevalence of Toxoplasma infection in the population of Iranian women.

Conclusions

This is the first comprehensive systematic review and meta-analysis of T. gondii in the overall population of women in our country. The data showed that 57% of Iranian pregnant women and 67% of girls and women of childbearing age were seronegative for Toxoplasma and susceptible to acute infection. Seronegative women are a high-risk group for congenital toxoplasmosis and should be monitored. We suggest that peer-led educational activities such as seminars and workshops are very effective, but they require great organizational efforts and lots of money and time. In Iran, there is no screening programme for women or seronegative pregnant women during gestation, but spouses are referred to health centres for premarital laboratory tests. It is necessary for the Ministry of Health to establish a screening programme and training course for couples who are referred to counselling departments for pre-marriage examinations. The risk factors for Toxoplasma should be documented in pamphlets and brochures with illustrations to make them easy to understand. However, didactic videos may serve as an effective teaching tool in these places. Importantly, health care organizations need to implement vast seroepidemiologic surveys on Toxoplasma infection in women and the disease risk factors using standardized methods, an identical sample size, and unique risk factors, to determine the true seropositivity rate in all provinces.

Declarations

Acknowledgements

The authors thank the Deputy of Research and Toxoplasmosis Research Centre (TRC) of Mazandaran University of Medical Sciences, Sari, Iran, for their kind provision.

Funding

No funding was received for this paper.

Availability of data and materials

Not applicable.

Authors’ contributions

All authors made a substantial contribution to this review. AM, AD, and MS participated in the study design. SS, AA, AS, SAH, and MTR participated in the data collection and literature searches. AM, AD, AAP, MS, SS, AA, AS, SAH, and MTR were involved and contributed to the data interpretation. AM, SS, and AA contributed to the creation of the figures and tables. AAP and AD participated in the data analysis. AM involved in the drafting of the article. AD, AAP, MS, SS, AA, AS, SAH, and MTR contributed to the critical revision of the article. All authors approved the final article for intellectual content with approval for publication with agreement towards accountability for all aspects of the article in regard to accuracy.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Toxoplasmosis Research Center, Mazandaran University of Medical Sciences
(2)
Parasitology and Mycology Department, School of Medicine, Mazandaran University of Medical Sciences
(3)
Student Research Committee, Mazandaran University of Medical Sciences
(4)
Community Medicine Department, School of Medicine, Mazandaran University of Medical Sciences

References

  1. Flegr J, Prandota J, Sovičková M, et al. Toxoplasmosis—a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. Plos One. 2014;9(3):e90203. Lancet Infect Dis. 2005;5(12):763 – 74.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30:1217–58.View ArticlePubMedPubMed CentralGoogle Scholar
  3. El Deeba HK, Salah Eldin H, Khodeerc S, et al. Prevalence of Toxoplasma gondii infection in antenatal population in Menoufia, governorate Egypt. Acta Trop. 2012;124:185–91.View ArticleGoogle Scholar
  4. Flegr J, Preiss M, Klose J, et al. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003;63:253–68.View ArticlePubMedGoogle Scholar
  5. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–8.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Kirby T. Calls for more detailed studies on toxoplasmosis. Lancet Infect Dis. 2012;12(12):912–3.View ArticlePubMedGoogle Scholar
  7. Goebel WS, Conway JH, Faught P, et al. Disseminated toxoplasmosis resulting in graft failure in a cord blood stem cell transplant recipient. Pediatr Blood Cancer. 2007;48:222–6.View ArticlePubMedGoogle Scholar
  8. Editorial. Toxoplasma gondii: an unknown quantity. Lancet Infect Dis. 2012;12(10):737.
  9. Daryani A, Sarvi S, Aarabi M, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014;137:185–94.View ArticlePubMedGoogle Scholar
  10. Borna S, Shariat M, Fallahi M, et al. Prevalence of immunity to toxoplasmosis among Iranian childbearing age women: systematic review and meta-analysis. Iran J Reprod Med. 2013;11(11):861–8.PubMedPubMed CentralGoogle Scholar
  11. Montoya JG, Boothroyd JC, Kovaks JA. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone; 2010. p. 3495–526.Google Scholar
  12. Sakikawa M, Noda S, Hanaoka M, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol. 2012;19(3):365–7.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Minkoff H, Remington JS, Holman S, et al. Vertical transmission of Toxoplasma by human immunodeficiency virus-infected women. Am J Obstet Gynecol. 1997;176(3):555–9.View ArticlePubMedGoogle Scholar
  14. Lindström I, Kaddu M, Kironde F, et al. Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patients from Uganda. Acta Trop. 2006;100:218–22.View ArticlePubMedGoogle Scholar
  15. Sarvi S, Daryani A, Rahimi MT, et al. Cattle toxoplasmosis in Iran: a systematic review and meta-analysis. Asian Pac J Trop Dis. 2015;8:120–6.View ArticleGoogle Scholar
  16. Ahmadpour E, Daryani A, Sharif M, et al. Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries. 2014;8(12):1503–10.View ArticlePubMedGoogle Scholar
  17. Meerburg BG, Kijlstra A. Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res. 2009;105:17–24.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Song KJ, Shin JC, Shin HJ, et al. Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol. 2005;43:69–71.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Buchy P, Follezou JY, Lien TX, et al. Serological study of toxoplasmosis in Vietnam in a population of drug users (Ho Chi Minh city) and pregnant women (NhaTrang). Bull Soc Pathol Exot. 2003;96:46–7.PubMedGoogle Scholar
  20. Rai SK, Shibata H, Sumi K, et al. Toxoplasma antibody prevalence in Nepalese pregnant women and women with bad obstetric history. SE Asian J Trop Med Public Health Med. 1998;29:739–43.Google Scholar
  21. Ertug S, Okyay P, Turkmen M, et al. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005;5(1):1–6.View ArticleGoogle Scholar
  22. Faisal IA, Khan AU, Waqar M, et al. Distribution of Toxoplasma gondii in the pregnant women of district Swabi Khyber Pakhtunkhwa Pakistan. World Appl Sci J. 2014;29(1):77–9.Google Scholar
  23. Yentur DN, Simsek Z, Gurses G, et al. Prevalence and associated risk factors of Toxoplasma gondii in female farm workers of southeastern Turkey. J Infect Dev Ctries. 2015;9(01):087–93.Google Scholar
  24. Galvan Ramirez MDLL, Troyo R, Roman S, et al. A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population. Parasit Vectors. 2012;5:271.View ArticlePubMed CentralGoogle Scholar
  25. Sharif M, Sarvi S, Shokri A, et al. Toxoplasma gondii infection among sheep and goats in Iran: a systematic review and meta-analysis. Parasitol Res. 2015;114:1–16.View ArticlePubMedGoogle Scholar
  26. Lopes FMR, Mitsuka Bregano R, Gonçalves DD, et al. Factors associated with seropositivity for anti-Toxoplasma gondii antibodies in pregnant women of Londrina, Paraná, Brazil. Mem Inst Oswaldo Cruz. 2009;104(2):378–82.View ArticlePubMedGoogle Scholar
  27. Sroka S, Bartelheimer N, Winter A, et al. Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, Northeastern Brazil. Am J Trop Med Hyg. 2010;83(3):528–33.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8:634–40.View ArticlePubMedGoogle Scholar
  29. Gelaye W, Kebede T, Hailu A. High prevalence of anti-Toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015;34:41–5.View ArticlePubMedGoogle Scholar
  30. Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38:1257–78.View ArticlePubMedGoogle Scholar
  31. Hung CS, Su HW, Lee Y, et al. Seroprevalence, seroconversion, and toxoplasmosis risk factors among pregnant women in Taipei City, Taiwan. Japanese J Infect Dis. 2015;68(4):312–17.
  32. Nimiri L, Pelloux H, Elkhatib L. Detection of Toxolasma gondii and specific antibodies in high-risk pregnant women. Am J Trop Med Hyg. 2004;71(6):831–5.Google Scholar
  33. Ayi I, Odoi-Kpoti Sowah A, Awusah Blay E, Suzuki T, Ohta N, Ayeh-Kumi PF. Toxoplasma gondii infections among pregnant women, children and HIV-seropositive persons in Accra, Ghana. Trop Med Health. 2016;44:17.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Montaya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Pract. 2008;47:554–66.Google Scholar
  35. Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2008;122:335–53.View ArticlePubMedGoogle Scholar
  36. Moghazy EI, Kandil FM, Shaapan RM. Toxoplasma gondii comparison of some erological tests for antibody detection in sera and naturally infected pigs. World Zool. 2011;6:204–8.Google Scholar
  37. Sharif M, Daryani A, Barzegar G, Nasrolahei M. A seroepidemiological survey for toxoplasmosis among schoolchildren of Sari, Northern Iran. Trop Biomed. 2010;27:220–5.PubMedGoogle Scholar
  38. Foroutan-Rad M, Khademvatan S, Majidiani H, et al. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: a systematic review and meta-analysis. Acta Trop. 2016;158:160–9.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement